| Product NDC: | 17312-015 |
| Proprietary Name: | Ring Relief |
| Non Proprietary Name: | ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA - |
| Active Ingredient(s): | 6; 6; 13; 6; 12; 13; 6; 13 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp; ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA - |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17312-015 |
| Labeler Name: | TRP Company |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 20111201 |
| Package NDC: | 17312-015-14 |
| Package Description: | 1 BOTTLE in 1 PACKAGE (17312-015-14) > 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
| NDC Code | 17312-015-14 |
| Proprietary Name | Ring Relief |
| Package Description | 1 BOTTLE in 1 PACKAGE (17312-015-14) > 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
| Product NDC | 17312-015 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA - |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20111201 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | TRP Company |
| Substance Name | ALLYLTHIOUREA; ARNICA MONTANA; CALCIUM SULFIDE; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SALICYLIC ACID; SILICON DIOXIDE |
| Strength Number | 6; 6; 13; 6; 12; 13; 6; 13 |
| Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
| Pharmaceutical Classes |